Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/31115
Full metadata record
DC FieldValueLanguage
dc.contributor.authorRasekh, M-
dc.contributor.authorArshad, MS-
dc.contributor.authorAhmad, Z-
dc.date.accessioned2025-05-01T21:19:44Z-
dc.date.available2025-05-01T21:19:44Z-
dc.date.issued2025-04-01-
dc.identifierORCiD: Muhammad Sohail Arshad https://orcid.org/0000-0001-9807-5841-
dc.identifierArticle number 456-
dc.identifier.citationRasekh, M., Arshad, M.S. and Ahmad, Z. (2025) 'Advances in Drug Delivery Integrated with Regenerative Medicine: Innovations, Challenges, and Future Frontiers' Pharmaceutics, 17 (4), 456, pp. 1 - 43. doi: 10.3390/pharmaceutics17040456.en_US
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/31115-
dc.descriptionData Availability Statement: Not applicable.en_US
dc.description.abstractAdvances in drug delivery systems adapted with regenerative medicine have transformed healthcare by introducing innovative strategies to treat (and repair in many instances) disease-impacted regions of the human body. This review provides a comprehensive analysis of the latest developments and challenges in integrating drug delivery technologies with regenerative medicine. Recent advances in drug delivery technologies, including the design of biomaterials, localized delivery techniques, and controlled release systems guided by mathematical models, are explored to illustrate their role in enhancing therapeutic precision and efficacy. Additionally, regenerative medicine approaches are analyzed, with a focus on extracellular matrix components, stem cell-based therapies, and emerging strategies for organ regeneration in both soft and hard tissue and in vitro model engineering. In particular, the review also discusses the applications of cellular components, including stem cells, immune cells, endothelial cells, and specialized cells such as chondrocytes and osteoblasts, and highlights advancements in cell delivery methods and cell–cell interaction modulation. In addition, future directions and pivotal trends emphasizing the importance of interdisciplinary collaboration and cutting-edge innovations are provided to address successful therapeutic outcomes in regenerative medicine.en_US
dc.description.sponsorshipThis study received no external funding.en_US
dc.format.extent1 - 43-
dc.format.mediumElectronic-
dc.language.isoen_USen_US
dc.publisherMDPIen_US
dc.rightsAttribution 4.0 International-
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.subjectregenerative medicineen_US
dc.subjectstem cellsen_US
dc.subjectdrug delivery systemsen_US
dc.subjectcontrolled releaseden_US
dc.subjectbioprintingen_US
dc.titleAdvances in Drug Delivery Integrated with Regenerative Medicine: Innovations, Challenges, and Future Frontiersen_US
dc.typeArticleen_US
dc.date.dateAccepted2025-03-26-
dc.identifier.doihttps://doi.org/10.3390/pharmaceutics17040456-
pubs.issue4-
pubs.volume17-
dc.identifier.eissn1999-4923-
dc.rights.licensehttps://creativecommons.org/licenses/by/4.0/legalcode.en-
dcterms.dateAccepted2025-03-26-
dc.rights.holderThe authors-
Appears in Collections:Dept of Electronic and Electrical Engineering Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).7.3 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons